|
1
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal
therapy for early breast cancer on recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 365:1687–1717. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Metzger-Filho O, Sun Z, Viale G, Price KN,
Crivellari D, Snyder RD, Gelber RD, Castiglione-Gertsch M, Coates
AS, Goldhirsch A and Cardoso F: Patterns of recurrence and outcome
according to breast cancer subtypes in lymph node-negative disease:
Results from international breast cancer study group trials VIII
and IX. J Clin Oncol. 31:3083–3090. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fisher CS, Cole DJ, Mitas M, Garrett-Meyer
E, Metcalf JS, Gillanders WE, Mikhitarian K, Urist MM, Mann GB,
Doherty G, et al: Molecular detection of micrometastatic breast
cancer in histopathology-negative axillary lymph nodes fails to
predict breast cancer recurrence: A final analysis of a prospective
multi-institutional cohort study. Ann Surg Oncol. 17 Suppl
3:S312–S320. 2010. View Article : Google Scholar
|
|
4
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
5
|
Taft RJ, Glazov EA, Cloonan N, Simons C,
Stephen S, Faulkner GJ, Lassmann T, Forrest AR, Grimmond SM,
Schroder K, et al: Tiny RNAs associated with transcription start
sites in animals. Nat Genet. 41:572–578. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Goswami RS, Waldron L, Machado J, Cervigne
NK, Xu W, Reis PP, Bailey DJ, Jurisica I, Crump MR and Kamel-Reid
S: Optimization and analysis of a quantitative real-time PCR-based
technique to determine microRNA expression in formalin-fixed
paraffin-embedded samples. BMC Biotechnol. 10:472010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Plummer PN, Freeman R, Taft RJ, Vider J,
Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, et al:
MicroRNAs regulate tumor angiogenesis modulated by endothelial
progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L,
Pan Q, He ML and Li XP: MicroRNA-10b induced by Epstein-Barr
virus-encoded latent membrane protein-1 promotes the metastasis of
human nasopharyngeal carcinoma cells. Cancer Lett. 299:29–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Setoyama T, Zhang X, Natsugoe S and Calin
GA: microRNA-10b: A new marker or the marker of pancreatic ductal
adenocarcinoma? Clin Cancer Res. 17:5527–5529. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang H, Liu J, Chen Y, Ma C, Li B and Hao
T: Up-regulation of mir-10b predicate advanced clinicopathological
features and liver metastasis in colorectal cancer. Cancer Med.
5:2932–2941. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosen PP and Oberman HA: Tumors of the
mammary gland. In: Atlas of Tumor Pathology. 3rd series, fascicle
7Armed Forces Institute of Pathology. Washington, DC: 1993
|
|
14
|
Niu Y, Fu X, Lv A, Fan Y and Wang Y:
Potential markers predicting distant metastasis in axillary
node-negative breast carcinoma. Int J Cancer. 98:754–760. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Wang F, Wang L, Wang W, Liu B,
Liu J, Chen M, He Q, Liao Y, Yu X, et al: Prevalence of chronic
kidney disease in China: A cross-sectional survey. Lancet.
379:815–822. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW,
Hsu JD, Ruan A, Chao KC and Han CP: Scoring mechanisms of p16INK4a
immunohistochemistry based on either independent nucleic stain or
mixed cytoplasmic with nucleic expression can significantly signal
to distinguish between endocervical and endometrial adenocarcinomas
in a tissue microarray study. J Transl Med. 7:252009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS,
Hayes M, et al: American society of clinical oncology/college of
American pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wolff AC, Hammond ME, Schwartz JN, Hagerty
KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer
A, et al: American society of clinical oncology/college of American
pathologists guideline recommendations for human epidermal growth
factor receptor 2 testing in breast cancer. J Clin Oncol.
25:118–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheang MC, Chia SK, Voduc D, Gao D, Leung
S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, et al: Ki67
index, HER2 status, and prognosis of patients with luminal B breast
cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goldhirsch A, Winer EP, Coates AS, Gelber
RD, Piccart-Gebhart M, Thürlimann B and Senn HJ: Panel members:
Personalizing the treatment of women with early breast cancer:
Highlights of the st Gallen International Expert consensus on the
primary therapy of early breast cancer. Ann Oncol. 24:2206–2223.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weidner N, Folkman J, Pozza F, Bevilacqua
P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis:
A new significant and independent prognostic indicator in
early-stage breast carcinoma. J Natl Cancer Inst. 84:1875–1887.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma L: Role of miR-10b in breast cancer
metastasis. Breast Cancer Res. 12:2102010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen X, Fang J, Lv X, Pei Z, Wang Y, Jiang
S and Ding K: Heparin impairs angiogenesis through inhibition of
microRNA-10b. J Biol Chem. 286:26616–26627. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van der Hage JA, Mieog JS, van de Velde
CJ, Putter H, Bartelink H and van de Vijver MJ: Impact of
established prognostic factors and molecular subtype in very young
breast cancer patients: Pooled analysis of four EORTC randomized
controlled trials. Breast Cancer Res. 13:R682011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baffa R, Fassan M, Volinia S, O'Hara B,
Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM and
Rosenberg A: MicroRNA expression profiling of human metastatic
cancers identifies cancer gene targets. J Pathol. 219:214–221.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang
YK and Yu ZS: Serum overexpression of microRNA-10b in patients with
bone metastatic primary breast cancer. J Int Med Res. 40:859–866.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Keyhani E, Muhammadnejad A, Behjati F,
Sirati F, Khodadadi F, Karimlou M, Moghaddam FA and Pazhoomand R:
Angiogenesis markers in breast cancer-potentially useful tools for
priority setting of anti-angiogenic agents. Asian Pac J Cancer
Prev. 14:7651–7656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Niemiec J, Adamczyk A, Ambicka A,
Mucha-Małecka A, Wysocki W, Mituś J and Ryś J: Lymphangiogenesis
assessed using three methods is related to tumour grade, breast
cancer subtype and expression of basal marker. Pol J Pathol.
63:165–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Muhammadnejad S, Muhammadnejad A, Haddadi
M, Oghabian MA, Mohagheghi MA, Tirgari F, Sadeghi-Fazel F and
Amanpour S: Correlation of microvessel density with nuclear
pleomorphism, mitotic count and vascular invasion in breast and
prostate cancers at preclinical and clinical levels. Asian Pac J
Cancer Prev. 14:63–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Plummer PN, Freeman R, Taft RJ, Vider J,
Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, et al:
MicroRNAs regulate tumor angiogenesis modulated by endothelial
progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Myers C, Charboneau A, Cheung I, Hanks D
and Boudreau N: Sustained expression of homeobox D10 inhibits
angiogenesis. Am J Pathol. 161:2099–2109. 2002. View Article : Google Scholar : PubMed/NCBI
|
